(Q56928447)

1

0 references

Jeff Boyd

2

0 references

Patrick I. Borgen

3

0 references

Hiram S. Cody

Current Problems in Surgery

4

0 references

publication date

June 2001

0 references

published in

0 references

volume

38

0 references

page(s)

387-480

0 references

issue

6

0 references

cites work

Cancer: the rise of the genetic paradigm

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2801%2970035-4

Nucleotide sequences related to the transforming gene of avian sarcoma virus are present in DNA of uninfected vertebrates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2801%2970035-4

Genetic and cellular basis of multistep carcinogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2801%2970035-4

Molecular themes in oncogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2801%2970035-4

The multistep nature of cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2801%2970035-4

How many mutations are required for tumorigenesis? Implications from human cancer data

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2801%2970035-4

Cooperation between oncogenes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2801%2970035-4

7 January 2021

Tumor suppressor genes

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2801%2970035-4

A mutation in the RET proto-oncogene associated with multiple endocrine neoplasia type 2B and sporadic medullary thyroid carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2801%2970035-4

Germline and somatic mutations in the tyrosine kinase domain of the MET proto-oncogene in papillary renal carcinomas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2801%2970035-4

Cancer-susceptibility genes. Gatekeepers and caretakers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2801%2970035-4

The clonal evolution of tumor cell populations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2801%2970035-4

Genetic instabilities in human cancers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2801%2970035-4

Genetic instability in colorectal cancers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2801%2970035-4

Identification of a chromosome 18q gene that is altered in colorectal cancers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2801%2970035-4

Cellular oncogenes and retroviruses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2801%2970035-4

Cell growth control by G protein-coupled receptors: from signal transduction to signal integration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2801%2970035-4

Increasing complexity of Ras signaling.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2801%2970035-4

Integrins and signal transduction pathways: the road taken

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2801%2970035-4

Growth factors and cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2801%2970035-4

Tyrosine kinase receptor with extensive homology to EGF receptor shares chromosomal location with neu oncogene

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2801%2970035-4

The neu oncogene: an erb-B-related gene encoding a 185,000-Mr tumour antigen

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2801%2970035-4

Phase II study of receptor-enhanced chemosensitivity using recombinant humanized anti-p185HER2/neu monoclonal antibody plus cisplatin in patients with HER2/neu-overexpressing metastatic breast cancer refractory to chemotherapy treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2801%2970035-4

Dose escalation and pharmacokinetic study of a humanized anti-HER2 monoclonal antibody in patients with HER2/neu-overexpressing metastatic breast cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2801%2970035-4

Rate-limiting steps: The genetics of pediatric cancers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2801%2970035-4

Expression of recessive alleles by chromosomal mechanisms in retinoblastoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2801%2970035-4

Mutations in p53 as potential molecular markers for human breast cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2801%2970035-4

Genetic epidemiology of breast cancer: segregation analysis of 200 Danish pedigrees.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2801%2970035-4

Inheritance of human breast cancer: evidence for autosomal dominant transmission in high-risk families

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2801%2970035-4

Family history, age, and risk of breast cancer. Prospective data from the Nurses' Health Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2801%2970035-4

The genetic attributable risk of breast and ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2801%2970035-4

Linkage of early-onset familial breast cancer to chromosome 17q21

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2801%2970035-4

Familial breast-ovarian cancer locus on chromosome 17q12-q23

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2801%2970035-4

Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2801%2970035-4

A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2801%2970035-4

Mutations in the BRCA1 gene in families with early-onset breast and ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2801%2970035-4

Common origins of BRCA1 mutations in Canadian breast and ovarian cancer families

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2801%2970035-4

Risks of cancer in BRCA1-mutation carriers. Breast Cancer Linkage Consortium

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2801%2970035-4

The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2801%2970035-4

BRCA1 mutations in primary breast and ovarian carcinomas.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2801%2970035-4

Promoter hypermethylation and BRCA1 inactivation in sporadic breast and ovarian tumors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2801%2970035-4

Localization of human BRCA1 and its loss in high-grade, non-inherited breast carcinomas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2801%2970035-4

Allele losses in the region 17q12-21 in familial breast and ovarian cancer involve the wild-type chromosome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2801%2970035-4

Ashkenazi Jewish population frequencies for common mutations in BRCA1 and BRCA2

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2801%2970035-4

The carrier frequency of the BRCA1 185delAG mutation is approximately 1 percent in Ashkenazi Jewish individuals

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2801%2970035-4

BRCA1 genomic deletions are major founder mutations in Dutch breast cancer patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2801%2970035-4

Evidence of founder mutations in Finnish BRCA1 and BRCA2 families

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2801%2970035-4

Founder BRCA1 and BRCA2 mutations in French Canadian breast and ovarian cancer families

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2801%2970035-4

Localization of a breast cancer susceptibility gene, BRCA2, to chromosome 13q12-13.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2801%2970035-4

Identification of the breast cancer susceptibility gene BRCA2

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2801%2970035-4

The complete BRCA2 gene and mutations in chromosome 13q-linked kindreds

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2801%2970035-4

Mutation analysis of the BRCA2 gene in 49 site-specific breast cancer families

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2801%2970035-4

BRCA2 germline mutations in male breast cancer cases and breast cancer families

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2801%2970035-4

Cancer risks in two large breast cancer families linked to BRCA2 on chromosome 13q12-13.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2801%2970035-4

Cancer risks in BRCA2 mutation carriers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2801%2970035-4

Absence of methylation of CpG dinucleotides within the promoter of the breast cancer susceptibility gene BRCA2 in normal tissues and in breast and ovarian cancers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2801%2970035-4

Recurrent BRCA2 6174delT mutations in Ashkenazi Jewish women affected by breast cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2801%2970035-4

The carrier frequency of the BRCA2 6174delT mutation among Ashkenazi Jewish individuals is approximately 1%

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2801%2970035-4

Germ-line BRCA1 mutations in Jewish and non-Jewish women with early-onset breast cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2801%2970035-4

Frequency and carrier risk associated with common BRCA1 and BRCA2 mutations in Ashkenazi Jewish breast cancer patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2801%2970035-4

Prevalence and Penetrance of BRCA1 and BRCA2 Gene Mutations in Unselected Ashkenazi Jewish Women With Breast Cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2801%2970035-4

The 8765delAG mutation in BRCA2 is common among Jews of Yemenite extraction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2801%2970035-4

Location of BRCA1 in human breast and ovarian cancer cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2801%2970035-4

BRCA1 is localized in cytoplasmic tube-like invaginations in the nucleus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2801%2970035-4

BRCA1 protein products ... Functional motifs...

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2801%2970035-4

Transcriptional activation by BRCA1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2801%2970035-4

Evidence for a transcriptional activation function of BRCA1 C-terminal region

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2801%2970035-4

BRCA1 is a component of the RNA polymerase II holoenzyme

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2801%2970035-4

BRCA1 regulates p53-dependent gene expression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2801%2970035-4

The developmental pattern of Brca1 expression implies a role in differentiation of the breast and other tissues

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2801%2970035-4

Expression of Brca1 is associated with terminal differentiation of ectodermally and mesodermally derived tissues in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2801%2970035-4

Growth retardation and tumour inhibition by BRCA1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2801%2970035-4

Association of BRCA1 with Rad51 in mitotic and meiotic cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2801%2970035-4

Dynamic changes of BRCA1 subnuclear location and phosphorylation state are initiated by DNA damage

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2801%2970035-4

The tumor suppressor gene Brca1 is required for embryonic cellular proliferation in the mouse

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2801%2970035-4

Partial rescue of Brca1 (5-6) early embryonic lethality by p53 or p21 null mutation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2801%2970035-4

Targeted mutations of breast cancer susceptibility gene homologs in mice: lethal phenotypes of Brca1, Brca2, Brca1/Brca2, Brca1/p53, and Brca2/p53 nullizygous embryos

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2801%2970035-4

BRCA1 required for transcription-coupled repair of oxidative DNA damage

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2801%2970035-4

Brca1 controls homology-directed DNA repair

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2801%2970035-4

BRCA1 is associated with the centrosome during mitosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2801%2970035-4

Centrosome amplification and a defective G2-M cell cycle checkpoint induce genetic instability in BRCA1 exon 11 isoform-deficient cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2801%2970035-4

Induction of GADD45 and JNK/SAPK-dependent apoptosis following inducible expression of BRCA1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2801%2970035-4

Genetic analysis of BRCA1 function in a defined tumor cell line

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2801%2970035-4

Requirement of ATM-dependent phosphorylation of brca1 in the DNA damage response to double-strand breaks

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2801%2970035-4

Functional link of BRCA1 and ataxia telangiectasia gene product in DNA damage response

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2801%2970035-4

hCds1-mediated phosphorylation of BRCA1 regulates the DNA damage response

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2801%2970035-4

The BRC repeats in BRCA2 are critical for RAD51 binding and resistance to methyl methanesulfonate treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2801%2970035-4

Changes in BRCA2 expression during progression of the cell cycle

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2801%2970035-4

Brca2 is coordinately regulated with Brca1 during proliferation and differentiation in mammary epithelial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2801%2970035-4

Cloning, chromosomal mapping and expression pattern of the mouse Brca2 gene

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2801%2970035-4

Developmental expression of Brca2 colocalizes with Brca1 and is associated with proliferation and differentiation in multiple tissues.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2801%2970035-4

Transcriptional activation functions in BRCA2

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2801%2970035-4

Embryonic lethality and radiation hypersensitivity mediated by Rad51 in mice lacking Brca2

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2801%2970035-4

Stable interaction between the products of the BRCA1 and BRCA2 tumor suppressor genes in mitotic and meiotic cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2801%2970035-4

Brca2 is required for embryonic cellular proliferation in the mouse

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2801%2970035-4

Tumorigenesis and a DNA repair defect in mice with a truncating Brca2 mutation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2801%2970035-4

Involvement of Brca2 in DNA repair

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2801%2970035-4

Double-strand break repair deficiency and radiation sensitivity in BRCA2 mutant cancer cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2801%2970035-4

Soft-tissue sarcomas, breast cancer, and other neoplasms. A familial syndrome?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2801%2970035-4

Genetic and pathologic findings in a kindred with hereditary sarcoma, breast cancer, brain tumors, leukemia, lung, laryngeal, and adrenal cortical carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2801%2970035-4

Multiple primary cancers in families with Li-Fraumeni syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2801%2970035-4

Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2801%2970035-4

Germ-line transmission of a mutated p53 gene in a cancer-prone family with Li-Fraumeni syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2801%2970035-4

Characterization of a 54K Dalton cellular SV40 tumor antigen present in SV40-transformed cells and uninfected embryonal carcinoma cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2801%2970035-4

T antigen is bound to a host protein in SY40-transformed cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2801%2970035-4

The p53 proto-oncogene can act as a suppressor of transformation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2801%2970035-4

Suppression of human colorectal carcinoma cell growth by wild-type p53

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2801%2970035-4

Genetic mechanisms of tumor suppression by the human p53 gene

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2801%2970035-4

Chromosome 17 deletions and p53 gene mutations in colorectal carcinomas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2801%2970035-4

p53 mutations in human cancers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2801%2970035-4

Crystal structure of a p53 tumor suppressor-DNA complex: understanding tumorigenic mutations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2801%2970035-4

Identification of p53 as a sequence-specific DNA-binding protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2801%2970035-4

Oncogenic forms of p53 inhibit p53-regulated gene expression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2801%2970035-4

Cell surface trafficking of Fas: a rapid mechanism of p53-mediated apoptosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2801%2970035-4

WAF1, a potential mediator of p53 tumor suppression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2801%2970035-4

The C-terminal domain of p53 recognizes DNA damaged by ionizing radiation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2801%2970035-4

p53 and its 14 kDa C-terminal domain recognize primary DNA damage in the form of insertion/deletion mismatches

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2801%2970035-4

Sensitivity and selectivity of the DNA damage sensor responsible for activating p53-dependent G1 arrest

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2801%2970035-4

DNA damage triggers a prolonged p53-dependent G1 arrest and long-term induction of Cip1 in normal human fibroblasts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2801%2970035-4

Requirement for p53 and p21 to sustain G2 arrest after DNA damage

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2801%2970035-4

Integrating genetic approaches into the discovery of anticancer drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2801%2970035-4

Heterozygous germ line hCHK2 mutations in Li-Fraumeni syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2801%2970035-4

Linkage of ATM to cell cycle regulation by the Chk2 protein kinase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2801%2970035-4

Increased risk of cancer in the Peutz-Jeghers syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2801%2970035-4

Cancer and the Peutz-Jeghers syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2801%2970035-4

Increased risk for cancer in patients with the Peutz-Jeghers syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2801%2970035-4

Localization of a susceptibility locus for Peutz-Jeghers syndrome to 19p using comparative genomic hybridization and targeted linkage analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2801%2970035-4

A serine/threonine kinase gene defective in Peutz-Jeghers syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2801%2970035-4

Peutz-Jeghers syndrome is caused by mutations in a novel serine threonine kinase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2801%2970035-4

Cloning and characterization of a novel serine/threonine protein kinase expressed in early Xenopus embryos

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2801%2970035-4

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2801%2970035-4

Cowden's disease. A possible new symptom complex with multiple system involvement

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2801%2970035-4

The dermatopathology of Cowden's syndrome*

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2801%2970035-4

The cutaneous pathology of Cowden's disease: new findings

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2801%2970035-4

PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2801%2970035-4

Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2801%2970035-4

PTEN1 is frequently mutated in primary endometrial carcinomas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2801%2970035-4

Analysis of PTEN and the 10q23 region in primary prostate carcinomas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2801%2970035-4

Inhibition of cell migration, spreading, and focal adhesions by tumor suppressor PTEN

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2801%2970035-4

Tumor suppressor PTEN inhibits integrin- and growth factor-mediated mitogen-activated protein (MAP) kinase signaling pathways

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2801%2970035-4

The PTEN/MMAC1 tumor suppressor phosphatase functions as a negative regulator of the phosphoinositide 3-kinase/Akt pathway

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2801%2970035-4

Hereditary nonpolyposis colorectal cancer: the syndrome, the genes, and historical perspectives.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2801%2970035-4

The International Collaborative Group on Hereditary Non-Polyposis Colorectal Cancer (ICG-HNPCC)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2801%2970035-4

The risk of endometrial cancer in hereditary nonpolyposis colorectal cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2801%2970035-4

Life-time risk of different cancers in hereditary non-polyposis colorectal cancer (HNPCC) syndrome.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2801%2970035-4

Cancer risk in families with hereditary nonpolyposis colorectal cancer diagnosed by mutation analysis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2801%2970035-4

Cancer risk associated with germline DNA mismatch repair gene mutations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2801%2970035-4

Extracolonic cancer in hereditary nonpolyposis colorectal cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2801%2970035-4

Risk of cancer death in first-degree relatives of patients with hereditary non-polyposis cancer syndrome (Lynch type II): a study of 130 kindreds in the United Kingdom

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2801%2970035-4

Familial clustering of colon, breast, uterine, and ovarian cancers as assessed by family history

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2801%2970035-4

Molecular genetic evidence of the occurrence of breast cancer as an integral tumor in patients with the hereditary nonpolyposis colorectal carcinoma syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2801%2970035-4

Male breast cancer in the hereditary nonpolyposis colorectal cancer syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2801%2970035-4

The Muir-Torre syndrome: a 25-year retrospect

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2801%2970035-4

Mutations predisposing to hereditary nonpolyposis colorectal cancer: Database and results of a collaborative study. The International Collaborative Group on Hereditary Nonpolyposis Colorectal Cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2801%2970035-4

Familial endometrial cancer in female carriers of MSH6 germline mutations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2801%2970035-4

Association of hereditary nonpolyposis colorectal cancer-related tumors displaying low microsatellite instability with MSH6 germline mutations.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2801%2970035-4

Structure of the human MSH2 locus and analysis of two Muir-Torre kindreds for msh2 mutations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2801%2970035-4

Identification of mismatch repair genes and their role in the development of cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2801%2970035-4

Mismatch repair: mechanisms and relationship to cancer susceptibility

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2801%2970035-4

Mutations of a mutS homolog in hereditary nonpolyposis colorectal cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2801%2970035-4

Loss of the wild type MLH1 gene is a feature of hereditary nonpolyposis colorectal cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2801%2970035-4

Mismatch repair gene defects in sporadic colorectal cancers with microsatellite instability

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2801%2970035-4

Mismatch repair, genetic stability, and cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2801%2970035-4

Incidence and functional consequences of hMLH1 promoter hypermethylation in colorectal carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2801%2970035-4

Inactivation of the type II TGF-beta receptor in colon cancer cells with microsatellite instability

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2801%2970035-4

Somatic frameshift mutations in the BAX gene in colon cancers of the microsatellite mutator phenotype.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2801%2970035-4

Familial colorectal cancer in Ashkenazim due to a hypermutable tract in APC.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2801%2970035-4

The APCI1307K allele and cancer risk in a community-based study of Ashkenazi Jews

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2801%2970035-4

The APCI1307K allele and breast cancer risk

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2801%2970035-4

The length and location of CAG trinucleotide repeats in the androgen receptor N-terminal domain affect transactivation function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2801%2970035-4

Modification of BRCA1-associated breast cancer risk by the polymorphic androgen-receptor CAG repeat

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2801%2970035-4

Population-based, case-control study of HER2 genetic polymorphism and breast cancer risk.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2801%2970035-4

Frequency of BRCA1/BRCA2 mutations in a population-based sample of young breast carcinoma cases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2801%2970035-4

Prevalence of BRCA1 and BRCA2 gene mutations in patients with early-onset breast cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2801%2970035-4

Breast conservation therapy for invasive breast cancer in Ashkenazi women with BRCA gene founder mutations.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2801%2970035-4

Influence of BRCA1 mutations on nuclear grade and estrogen receptor status of breast carcinoma in Ashkenazi Jewish women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2801%2970035-4

Germline BRCA1 185delAG mutations in Jewish women with breast cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2801%2970035-4

Frequency of recurrent BRCA1 and BRCA2 mutations in Ashkenazi Jewish breast cancer families

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2801%2970035-4

Significantly lower rates of BRCA1/BRCA2 founder mutations in Ashkenazi women with sporadic compared with familial early onset breast cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2801%2970035-4

Prevalence of recurring BRCA mutations among Ashkenazi Jewish women with breast cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2801%2970035-4

Three per cent of Norwegian Ovarian Cancers are caused by BRCA1 1675delA or 1135insA

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2801%2970035-4

New BRCA2 mutation in an Ashkenazi Jewish family with breast and ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2801%2970035-4

BRCA1 and BRCA2 mutations in Ashkenazi Jewish families with breast and ovarian cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2801%2970035-4

Screening for genomic rearrangements in families with breast and ovarian cancer identifies BRCA1 mutations previously missed by conformation-sensitive gel electrophoresis or sequencing

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2801%2970035-4

The Exon 13 Duplication in the BRCA1 Gene Is a Founder Mutation Present in Geographically Diverse Populations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2801%2970035-4

Absence of germline mutations of exons 5 to 8 of the P53 gene in 26 breast cancer families from the north of France

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2801%2970035-4

Screening for germline mutations of the p53 gene in familial breast cancer patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2801%2970035-4

The ATM gene and breast cancer: is it really a risk factor?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2801%2970035-4

Cancer risk and the ATM gene: a continuing debate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2801%2970035-4

Heterozygous ATM mutations do not contribute to early onset of breast cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2801%2970035-4

ATM-heterozygous germline mutations contribute to breast cancer-susceptibility

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2801%2970035-4

ATM mutations and phenotypes in ataxia-telangiectasia families in the British Isles: expression of mutant ATM and the risk of leukemia, lymphoma, and breast cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2801%2970035-4

Germline mutations in PTEN are an infrequent cause of genetic predisposition to breast cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2801%2970035-4

The role of MMAC1 mutations in early-onset breast cancer: causative in association with Cowden syndrome and excluded in BRCA1-negative cases.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2801%2970035-4

Differential Contributions ofBRCA1andBRCA2to Early-Onset Breast Cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2801%2970035-4

Tumour biological features of BRCA1-induced breast and ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2801%2970035-4

Multifactorial analysis of differences between sporadic breast cancers and cancers involving BRCA1 and BRCA2 mutations.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2801%2970035-4

Hereditary breast cancer: pathobiology, prognosis, and BRCA1 and BRCA2 gene linkage

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2801%2970035-4

Survival and tumour characteristics of breast-cancer patients with germline mutations of BRCA1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2801%2970035-4

Histoprognostic grade in tumours from families with hereditary predisposition to breast cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2801%2970035-4

The histologic phenotypes of breast carcinoma occurring before age 40 years in women with and without BRCA1 or BRCA2 germline mutations: a population-based study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2801%2970035-4

Pathobiologic characteristics of hereditary breast cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2801%2970035-4

Clinicopathologic analysis of BRCA1- or BRCA2-associated hereditary breast carcinoma in Japanese women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2801%2970035-4

Frequency of p53 mutations in breast carcinomas from Ashkenazi Jewish carriers of BRCA1 mutations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2801%2970035-4

BRCA1and Medullary Breast Cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2801%2970035-4

BRCA-associated breast cancer in young women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2801%2970035-4

Inherited BRCA2 mutation associated with high grade breast cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2801%2970035-4

BRCA2 hereditary breast cancer pathophenotype

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2801%2970035-4

Survival in hereditary breast cancer associated with germline mutations of BRCA2.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2801%2970035-4

p53 mutation with frequent novel condons but not a mutator phenotype in BRCA1- and BRCA2-associated breast tumours

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2801%2970035-4

Breast cancer survival in BRCA1 carriers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2801%2970035-4

Breast cancer incidence, penetrance and survival in probable carriers of BRCA1 gene mutation in families linked to BRCA1 on chromosome 17q12-21

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2801%2970035-4

Survival of BRCA1 breast and ovarian cancer patients: a population-based study from southern Sweden

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2801%2970035-4

Response to radiation therapy and prognosis in breast cancer patients with BRCA1 and BRCA2 mutations.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2801%2970035-4

Survival and tumor characteristics of German hereditary breast cancer patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2801%2970035-4

Effect of Radiotherapy After Breast-Conserving Treatment in Women With Breast Cancer and Germline BRCA1/2 Mutations

7 January 2021

2 references

https://api.crossref.org/works/10.1016%2FS0011-3840%2801%2970035-4

7 January 2021

https://api.crossref.org/works/10.1016%2FS0011-3840%2801%2970035-4

inferred from DOI database lookup

7 January 2021

based on heuristic

Survival in early-onset BRCA1 breast-cancer patients. Institut Curie Breast Cancer Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2801%2970035-4

BRCA mutations and survival in breast cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2801%2970035-4

Survival of patients with breast cancer and BRCA1 mutations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2801%2970035-4

Primary node negative breast cancer in BRCA1 mutation carriers has a poor outcome.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2801%2970035-4

Prognosis and clinical presentation of BRCA2-associated breast cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2801%2970035-4

Contralateral breast cancer risk is influenced by the age at onset in BRCA1-associated breast cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2801%2970035-4

BRCA1 and BRCA2 mutation analysis of 208 Ashkenazi Jewish women with ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2801%2970035-4

Population-based study of risk of breast cancer in carriers of BRCA2 mutation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2801%2970035-4

Risk modifiers in carriers of brca1 mutations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2801%2970035-4

Pregnancy and risk of early breast cancer in carriers of BRCA1 and BRCA2

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2801%2970035-4

Pregnancy-associated breast cancer in BRCA1 and BRCA2 germline mutation carriers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2801%2970035-4

Breast cancer risk after bilateral prophylactic oophorectomy in BRCA1 mutation carriers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2801%2970035-4

Effect of Smoking on Breast Cancer in Carriers of Mutant BRCA1 or BRCA2 Genes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2801%2970035-4

Germline mutations of the BRCA1 gene in breast and ovarian cancer families provide evidence for a genotype–phenotype correlation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2801%2970035-4

Ovarian cancer risk in BRCA1 carriers is modified by the HRAS1 variable number of tandem repeat (VNTR) locus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2801%2970035-4

The Jewish Ashkenazi founder mutations in the BRCA1/BRCA2 genes are not found at an increased frequency in Ashkenazi patients with prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2801%2970035-4

Common mutations in BRCA1 and BRCA2 do not contribute to early prostate cancer in Jewish men.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2801%2970035-4

The rate of the founder Jewish mutations in BRCA1 and BRCA2 in prostate cancer patients in Israel

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2801%2970035-4

No evidence for a role of BRCA1 or BRCA2 mutations in Ashkenazi Jewish families with hereditary prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2801%2970035-4

Incidence of malignant tumours in relatives of BRCA1 and BRCA2 germline mutation carriers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2801%2970035-4

BRCA2 mutation in Icelandic prostate cancer patients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2801%2970035-4

Recommendations for follow-up care of individuals with an inherited predisposition to cancer. II. BRCA1 and BRCA2. Cancer Genetics Studies Consortium

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2801%2970035-4

Recommendations for medical management of hereditary breast and ovarian cancer: the French National Ad Hoc Committee

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2801%2970035-4

Establishment and characterization of a breast cell strain containing a BRCA1 185delAG mutation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2801%2970035-4

Earlier detection of breast cancer by surveillance of women at familial risk

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2801%2970035-4

Occult cancer in women with dense breasts: detection with screening US--diagnostic yield and tumor characteristics.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2801%2970035-4

Breast MR imaging screening in 192 women proved or suspected to be carriers of a breast cancer susceptibility gene: preliminary results.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2801%2970035-4

Occult ovarian tumors in women with BRCA1 or BRCA2 mutations undergoing prophylactic oophorectomy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2801%2970035-4

The efficacy of transvaginal sonographic screening in asymptomatic women at risk for ovarian cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2801%2970035-4

Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2801%2970035-4

Oral contraceptives and the risk of hereditary ovarian cancer. Hereditary Ovarian Cancer Clinical Study Group.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2801%2970035-4

Genetic and hormonal risk factors in breast cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2801%2970035-4

Understanding the relationship between relative and absolute risk

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2801%2970035-4

Projecting individualized probabilities of developing breast cancer for white females who are being examined annually

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2801%2970035-4

Comparing radical mastectomy with quadrantectomy, axillary dissection, and radiotherapy in patients with small cancers of the breast

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2801%2970035-4

Reanalysis and results after 12 years of follow-up in a randomized clinical trial comparing total mastectomy with lumpectomy with or without irradiation in the treatment of breast cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2801%2970035-4

Five-year results of a randomized clinical trial comparing total mastectomy and segmental mastectomy with or without radiation in the treatment of breast cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2801%2970035-4

Eight-year results of a randomized clinical trial comparing total mastectomy and lumpectomy with or without irradiation in the treatment of breast cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2801%2970035-4

Adjuvant radiotherapy and chemotherapy in node-positive premenopausal women with breast cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2801%2970035-4

Postoperative radiotherapy in high-risk premenopausal women with breast cancer who receive adjuvant chemotherapy. Danish Breast Cancer Cooperative Group 82b Trial.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2801%2970035-4

Family history of breast cancer and local recurrence after breast-conserving therapy. The Dutch Study Group on Local Recurrence after Breast Conservation (BORST).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2801%2970035-4

Family history and treatment outcome in young women after breast-conserving surgery and radiation therapy for early-stage breast cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2801%2970035-4

BRCA1/BRCA2 germline mutations in locally recurrent breast cancer patients after lumpectomy and radiation therapy: implications for breast-conserving management in patients with BRCA1/BRCA2 mutations.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2801%2970035-4

Contralateral breast cancer and other second malignancies in patients treated by breast-conserving therapy with radiation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2801%2970035-4

Some anatomical considerations of subcutaneous mastectomy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2801%2970035-4

Technical considerations for prophylactic mastectomy in patients at high risk for breast cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2801%2970035-4

Cancer of the breast after prophylactic subcutaneous mastectomy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2801%2970035-4

Failure of subcutaneous mastectomy to prevent the development of breast cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2801%2970035-4

Primary breast cancer after prophylactic mastectomy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2801%2970035-4

Breast cancer after prophylactic subcutaneous mastectomies and reconstructionwith silastic prostheses.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2801%2970035-4

Subcutaneous mastectomy data: a final statistical analysis of 1500 patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2801%2970035-4

Subcutaneous mastectomy: current state of the art

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2801%2970035-4

Detailed technique of subcutaneous mastectomy with and without mastopexy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2801%2970035-4

Total glandular mastectomy. Modifications of the subcutaneous mastectomy for use in premalignant disease of the breast

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2801%2970035-4

Skin-sparing mastectomy. Oncologic and reconstructive considerations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2801%2970035-4

Presentation, treatment, and outcome of local recurrence afterskin-sparing mastectomy and immediate breast reconstruction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2801%2970035-4

Immediate reconstruction after complete skin-sparing mastectomy with autologous tissue

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2801%2970035-4

Local and distant recurrence rates in skin-sparing mastectomies compared with non-skin-sparing mastectomies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2801%2970035-4

Breast tumor incidence in rats after partial mammary resection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2801%2970035-4

Breast cancer incidence subsequent to surgical reduction of the female breast

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2801%2970035-4

Efficacy of Bilateral Prophylactic Mastectomy in Women with a Family History of Breast Cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2801%2970035-4

Comparative Studies of Cancerous Versus Noncancerous Breasts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2801%2970035-4

BILATERAL PRIMARY BREAST CANCER; A PROSPECTIVE CLINICOPATHOLOGICAL STUDY.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2801%2970035-4

Selective, elective, prophylactic contralateral mastectomy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2801%2970035-4

The contralateral breast at reconstructive surgery after breast cancer operation--a histopathological study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2801%2970035-4

Bilateral breast cancer: the frequency of undiagnosed cancers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2801%2970035-4

The contralateral breast in ipsilateral breast carcinoma.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2801%2970035-4

Synchronous elective contralateral mastectomy and immediate bilateral breast reconstruction in women with early-stage breast cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2801%2970035-4

Arguments against routine contralateral mastectomy or undirected biopsy for invasive lobular breast cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2801%2970035-4

Synchronous, bilateral mastectomy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2801%2970035-4

Routine contralateral breast biopsy: helpful or irrelevant? Experience in 871 patients, 1979-1993.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2801%2970035-4

Prognosis in T2N0M0 stage I breast carcinoma: a 20-year follow-up study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2801%2970035-4

A descriptive study of BRCA1 testing and reactions to disclosure of test results

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2801%2970035-4

Presymptomatic DNA testing and prophylactic surgery in families with a BRCA1 or BRCA2 mutation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2801%2970035-4

Acceptability of prophylactic mastectomy in cancer-prone women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2801%2970035-4

Predictors of and satisfaction with bilateral prophylactic mastectomy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2801%2970035-4

Issues of regret in women with contralateral prophylactic mastectomies.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2801%2970035-4

Patient regrets after bilateral prophylactic mastectomy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2801%2970035-4

Women's regrets after bilateral prophylactic mastectomy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2801%2970035-4

Long-term satisfaction and psychological and social function following bilateral prophylactic mastectomy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2801%2970035-4

Complications of gynecologic laparoscopic surgery--a French multicenter collaborative study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2801%2970035-4

Menstrual factors and risk of breast cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2801%2970035-4

Papillary serous carcinoma of the peritoneum in women. A clinicopathologic and immunohistochemical study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2801%2970035-4

Primary peritoneal carcinoma after prophylactic oophorectomy in women with a family history of ovarian cancer. A report of the Gilda Radner Familial Ovarian Cancer Registry.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2801%2970035-4

Decision analysis--effects of prophylactic mastectomy and oophorectomy on life expectancy among women with BRCA1 or BRCA2 mutations.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2801%2970035-4

Life expectancy gains from cancer prevention strategies for women with breast cancer and BRCA1 or BRCA2 mutations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2801%2970035-4

Decision analysis of prophylactic mastectomy and oophorectomy in BRCA1-positive or BRCA2-positive patients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2801%2970035-4

Low frequency of lymph-node metastasis in BRCA1-associated breast cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2801%2970035-4

Predicted anti-oestrogen resistance in BRCA-associated familial breast cancers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2801%2970035-4

p53 mutations in BRCA1-associated familial breast cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2801%2970035-4

Novel indications for BRCA1 screening using individual clinical and morphological features

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2801%2970035-4

Effectiveness of prophylactic mastectomy in the prevention of breast tumors in C3H mice.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2801%2970035-4